To include your compound in the COVID-19 Resource Center, submit it here.

FDA: Bial-Portela's FAAH inhibitor has "unique toxicity"

In its safety review of fatty acid amide hydrolase ( FAAH) inhibitors, FDA concluded that BIA 10-2474 from Bial-Portela & Ca. S.A.

Read the full 225 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE